Clinical Trials on Hepatocellular Carcinoma Stage IV in Hong Kong

Total 240 results

Our Lady of Maryknoll Hospital
Wong Tai Sin Hospital

Unknown

The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers

Pressure Ulcers Stage III | Pressure Ulcer, Stage IV

Hong Kong
Humanity & Health Medical Group Limited

Recruiting

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Hepatocellular Carcinoma

Hong Kong
Humanity & Health Medical Group Limited
Beijing 302 Hospital; Kindai University Faculty of Medicine

Terminated

Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors

NSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB

Hong Kong
The University of Hong Kong

Completed

Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT

Hepatocellular Carcinoma Non-resectable | Stereotactic Body Radiotherapy

Hong Kong
The University of Hong Kong

Unknown

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma (SECOX)

Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

China
Aegera Therapeutics
Chinese University of Hong Kong

Completed

XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma

China
Lee's Pharmaceutical Limited

Recruiting

Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

Advanced Hepatocellular Carcinoma

China
Chinese University of Hong Kong
Health and Medicine Research Fund

Recruiting

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
The Hong Kong Society of Gastroenterology

Completed

Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Recruiting

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Terminated

Chemoembolization for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (BCT-100-002)

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC)_Torisel_

Inoperable HCC

Hong Kong
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Recruiting

Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

TACE Emulsion Versus Suspension

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Completed

SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Completed

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Unknown

SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
CCTU

Recruiting

Pembrolizumab in Hepatocellular Carcinoma

HCC

Hong Kong
The University of Hong Kong

Recruiting

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

HCC

Hong Kong
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
Dr Tan-to CHEUNG

Completed

Neoadjuvant Anti-PD1 in HCC

HCC | Hepatocellular Carcinoma | Liver Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Fibroscan Study in HCC

Confirmed Diagnosis of Hepatocellular Carcinoma | Patients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy Surgery | Child's A to C Cirrhosis

Hong Kong
Chinese University of Hong Kong

Completed

Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Completed

Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation

Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Completed

RCT on Adjuvant TACE After Hepatectomy for HCC (A-TECH)

Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Not yet recruiting

Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors (PDO)

Hepatocellular Carcinoma | Colorectal Cancer

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

EUS Guided Cyanoacrylate Injection vs Endoscopic Variceal Band Ligation for Prevention of Rebleeding in Patients With Hepatocellular Carcinoma and Esophageal Variceal Bleeding (EUSgluevsVBL)

EUS Guided Cyanoacrylate Injection | Endoscopic Variceal Band Ligation | Hepatocelular Carcinoma | Esophageal Variceal Bleeding

Hong Kong
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Terminated

Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Terminated

A Study on the Angioarchitecture of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
Chinese University of Hong Kong

Terminated

Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
The University of Hong Kong

Completed

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Secondary

Hong Kong
Humanity & Health Medical Group Limited

Withdrawn

A Study to Evaluate Vaccines Against COVID-19 in the Real World

Chronic Liver Disease | Hepatic Carcinoma

Hong Kong
The University of Hong Kong

Recruiting

Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion

Pleural Effusion, Malignant | Lung Cancer Stage IV | Chest Tubes

Hong Kong
Hospital Authority, Hong Kong
Schering-Plough

Unknown

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Carcinoma, Hepatocellular

China
Chinese University of Hong Kong

Recruiting

Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function

Carcinoma, Hepatocellular

Hong Kong
Nam Dinh University of Nursing
The Hong Kong Polytechnic University

Completed

Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.

Lung Cancer, Nonsmall Cell | Lung Cancer Non-Small Cell Stage 0 | Lung Cancer, Nonsmall Cell, Stage I | Lung Cancer Non-Small Cell Stage II | Lung Cancer, Limited Stage Small Cell

Hong Kong
Stephen Chan Lam

Active, not recruiting

Cabozantinib in Hepatocellular Carcinoma

HCC

Korea, Republic of, Hong Kong
The University of Hong Kong

Recruiting

Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Circulating Tumor Cell

China
Humanity & Health Medical Group Limited
Tokyo University

Recruiting

The Overall Survival of Patients With Unresectable HCC in Real-life

Hepatocellular Carcinoma

Japan, China, Hong Kong
Chinese University of Hong Kong

Recruiting

Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients (EUS-SPV)

Hepatocellular Carcinoma | Variceal Bleeding

Hong Kong
AstraZeneca

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients

Cancer | Advanced Hepatocellular Carcinoma

Korea, Republic of, Hong Kong

Clinical Trials on Hepatocellular Carcinoma Stage IV in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations